INABIN8BIO, INC.vs its industry peers
A metric-by-metric comparison of IN8BIO, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INAB본 종목 | $9M#2 | — | 0.4x#1 | — | — | 36.1%#1 | — | -85.3%#1 | — | — | -54.5%#3 | — |
| BCLI | $13M#1 | — | — | — | — | 11.3%#3 | — | — | — | — | -1.7%#2 | — |
| SLXN | $8M#3 | 0.3x#1 | 26.1x#2 | — | — | 27.9%#2 | — | -4093.5%#2 | — | — | -98.0%#5 | — |
| BCAB | — | 0.4x#2 | — | — | — | -14.6%#4 | -19768.3%#2 | — | — | — | -80.4%#4 | — |
| LIMN | $5M#4 | — | — | — | — | -187.8%#6 | — | — | -226.6%#1 | — | -98.1%#6 | — |
| ZIVO | $5M#5 | — | — | 31.3x#1 | 468.6%#1 | -72.1%#5 | -8498.9%#1 | — | — | — | 0.0%#1 | — |
| CERO | $4M#6 | — | — | — | — | — | — | — | — | — | — | 2.9%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice